Frontiers in Pharmacology | Respiratory Pharmacology

Review

Published on 19 Apr 2021

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases

in Respiratory Pharmacology

Sara Rolandsson Enes
Anna D. Krasnodembskaya
Karen English
Claudia C. Dos Santos
Daniel J. Weiss

Frontiers in Pharmacology

doi 10.3389/fphar.2021.647652

3,420 views
13 citations

Original Research

Published on 19 Apr 2021

miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease

in Respiratory Pharmacology

Weiwei Yu
Ting Ye
Jie Ding
Yi Huang
Yang Peng
Qin Xia
Zhang Cuntai

Frontiers in Pharmacology

doi 10.3389/fphar.2021.551839

4,534 views
13 citations

Original Research

Published on 19 Apr 2021

Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma

in Respiratory Pharmacology

Mario Malerba
Beatrice Ragnoli
Danila Azzolina
Paolo Montuschi
Alessandro Radaeli

Frontiers in Pharmacology

doi 10.3389/fphar.2021.630334

3,229 views
6 citations

Original Research

Published on 15 Apr 2021

Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway

in Respiratory Pharmacology

Wanyun Zuo
Na Liu
Yunhong Zeng
Zhenghui Xiao
Keke Wu
Fan Yang
Biao Li
Qingqing Song
Yunbin Xiao
Qiming Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.663551

7,619 views
53 citations

Review

Published on 15 Apr 2021

Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases

in Respiratory Pharmacology

Linda Elowsson Rendin
Anna Löfdahl
Måns Kadefors
Zackarias Söderlund
Emil Tykesson
Sara Rolandsson Enes
Jenny Wigén
Gunilla Westergren-Thorsson

Frontiers in Pharmacology

doi 10.3389/fphar.2021.645558

5,204 views
12 citations

Mini Review

Published on 15 Apr 2021

Cystic Fibrosis Lung Disease in the Aging Population

in Respiratory Pharmacology

Lisa Künzi
Molly Easter
Meghan June Hirsch
Stefanie Krick

Frontiers in Pharmacology

doi 10.3389/fphar.2021.601438

7,746 views
11 citations

Original Research

Published on 12 Apr 2021

Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway

in Respiratory Pharmacology

Xiaohe Li
Kai Huang
Xiaowei Liu
Hao Ruan
Ling Ma
Jingjing Liang
Yunyao Cui
Yanhua Wang
Shuyang Wu
Hailong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.639574

4,662 views
19 citations

Original Research

Published on 12 Apr 2021

Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking

in Respiratory Pharmacology

De Jin
Xuedong An
Yuqing Zhang
Shenghui Zhao
Liyun Duan
Yingying Duan
Fengmei Lian
Xiaolin Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.602218

6,119 views
12 citations

Editorial

Published on 12 Apr 2021

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases

in Respiratory Pharmacology

Juraj Mokry
Mark Giembycz
Daniela Mokra

Frontiers in Pharmacology

doi 10.3389/fphar.2021.657596

1,893 views
2 citations

Original Research

Published on 05 Apr 2021

Possible Tracheal Relaxant and Antimicrobial Effects of the Essential Oil of Ethiopian Thyme Species (Thymus serrulatus Hochst. ex Benth.): A Multiple Mechanistic Approach

in Respiratory Pharmacology

Najeeb Ur Rehman
Mohd Nazam Ansari
Tesfay Haile
Aman Karim
Khalil Y Abujheisha
Syed Rizwan Ahamad
Faisal Imam

Frontiers in Pharmacology

doi 10.3389/fphar.2021.615228

5,430 views
5 citations

Original Research

Published on 30 Mar 2021

Brusatol Derivative–34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway

in Respiratory Pharmacology

Yasi Ding
Weibin Tang
Fei Pei
Lixia Fu
Pei Ma
Jinye Bai
Mingbao Lin
Yunbao Liu
Qi Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.587417

2,411 views
6 citations

Original Research

Published on 25 Mar 2021

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

in Respiratory Pharmacology

Jordi Rodon
Jordana Muñoz-Basagoiti
Daniel Perez-Zsolt
Marc Noguera-Julian
Roger Paredes
Lourdes Mateu
Carles Quiñones
Carles Perez
Itziar Erkizia
Ignacio Blanco

Frontiers in Pharmacology

doi 10.3389/fphar.2021.646676

14,181 views
49 citations

Original Research

Published on 23 Mar 2021

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

in Respiratory Pharmacology

Robert W. Malone
Philip Tisdall
Philip Fremont-Smith
Yongfeng Liu
Xi-Ping Huang
Kris M. White
Lisa Miorin
Elena Moreno
Assaf Alon
Elise Delaforge

Frontiers in Pharmacology

doi 10.3389/fphar.2021.633680

189,791 views
84 citations

Mini Review

Published on 16 Mar 2021

Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies

in Respiratory Pharmacology

Katelin M. Allan
Nigel Farrow
Martin Donnelley
Adam Jaffe
Shafagh A. Waters

Frontiers in Pharmacology

doi 10.3389/fphar.2021.639475

27,434 views
27 citations

Original Research

Published on 08 Mar 2021

Oral Formulation of Angiotensin-(1-7) Promotes Therapeutic Actions in a Model of Eosinophilic and Neutrophilic Asthma

in Respiratory Pharmacology

Giselle Santos Magalhães
Juliana Fabiana Gregório
Arthur Tonani Pereira Cançado Ribeiro
Isis Felippe Baroni
Ana Victoria de Oliveira Vasconcellos
Gabriela Pansanato Nakashima
Isabel Fusaro Aguiar Oliveira
Natália Alves de Matos
Thalles de Freitas Castro
Frank Silva Bezerra

Frontiers in Pharmacology

doi 10.3389/fphar.2021.557962

3,399 views
5 citations

Original Research

Published on 22 Feb 2021

The Influenza A Virus H3N2 Triggers the Hypersusceptibility of Airway Inflammatory Response via Activating the lncRNA TUG1/miR-145-5p/NF-κB Pathway in COPD

in Respiratory Pharmacology

You-Hui Tu
Yan Guo
Shuang Ji
Ji-Long Shen
Guang-He Fei

Frontiers in Pharmacology

doi 10.3389/fphar.2021.604590

3,986 views
10 citations

Navigation group

Articles

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases

miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease

Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma

Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway

Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases

Cystic Fibrosis Lung Disease in the Aging Population

Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway

Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases

Possible Tracheal Relaxant and Antimicrobial Effects of the Essential Oil of Ethiopian Thyme Species (Thymus serrulatus Hochst. ex Benth.): A Multiple Mechanistic Approach

Brusatol Derivative–34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies

Oral Formulation of Angiotensin-(1-7) Promotes Therapeutic Actions in a Model of Eosinophilic and Neutrophilic Asthma

The Influenza A Virus H3N2 Triggers the Hypersusceptibility of Airway Inflammatory Response via Activating the lncRNA TUG1/miR-145-5p/NF-κB Pathway in COPD